Navigation Links
Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients
Date:3/31/2008

ponsored by the National Heart, Lung and Blood Institute recommend initial combination therapy of two medications that work differently for patients who have a systolic blood pressure of 20 mmHg and a diastolic blood pressure of 10 mmHg over target goal. Systolic blood pressure is the pressure of blood flow as the heart beats and pushes blood throughout the body. Diastolic blood pressure is between heart beats, as your heart rests and refills with blood.

Approximately 73 million adults (nearly one in three) in the US have high blood pressure. It has been estimated that most adults with high blood pressure also have additional health problems that increase their risk for cardiovascular events.

Novartis: strength in cardiovascular and metabolic diseases

Novartis is focused on improving the lives of the hundreds of millions of people with diseases of the cardiovascular and metabolic systems. As a global leader and innovator in cardiovascular and metabolic health, Novartis provides novel therapies and support programs to treat high blood pressure and major public health issues. The strength of Novartis lies in its broad range of renin-angiotensin system (RAS) based therapies for the treatment of high blood pressure, which include the most prescribed angiotensin-receptor-blocker, the first approved oral direct renin inhibitor and a single agent combining two of the most prescribed antihypertensive medicines. Novartis has an extensive clinical research program in hypertension involving more than 100,000 patients. Novartis is dedicated to helping physicians and patients address cardiovascular and metabolic health through effective medicines and an ongoing commitment to education, support and research.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "will", "suggest", "committed", or similar expressions, or by express or implied discussions regarding potential new indicatio
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
2. ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
3. New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy
4. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
5. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
6. Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
7. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
8. New Drug Combination is Able to Eradicate Breast Metastases in Mice
9. Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma
10. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Stem Cell Transplantation
11. Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... TAMPA, Fla. , July 28, 2015  For ... by their researchers, physicians and other inventors can be ... to market is difficult, and successes are rare. ... wants to change that. Medical Device ... technology licensed from universities, hospitals and physicians. MDI develops, ...
(Date:7/28/2015)... PLEASANTON, Calif. , July 28, 2015 /PRNewswire/ ... tremendous burden that pressure ulcers place on the ... are a leading threat to modern quality healthcare. ... Human Services, Agency for Healthcare Research and Quality ... system more than $11 billion a year. The ...
(Date:7/28/2015)... 2015 Mike Rowe , spokesperson and reality ... Neighbor Pharmacy,s 2015 ThoughtSpot conference and tradeshow, ... Las Vegas, Nev. Best ... It," and Discovery Channel,s, "Dirty Jobs," Mr. Rowe spent a ... heroes" – people whose hard work, sacrifice and value aren,t ...
Breaking Medicine Technology:Medical Device Investments To Become Center Of Excellence For The Commercialization Of Innovative Medical Technologies 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 3Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2
... (NYSE: SHP ) ("ShangPharma" or the "Company"), ... outsourcing company, today announced shareholder resolutions adopted at its ... today. ShangPharma,s shareholders adopted the following ... 1. THAT the 2011 Share Incentive ...
... 2011 Young Innovations, Inc. (NASDAQ - YDNT) today announced ... a live and on-demand web cast conference call on Thursday, ... audio broadcast of the call will be available through InterCall ... will also be available through the Company,s website, www.ydnt.com ...
Cached Medicine Technology:ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting 2Young Innovations, Inc. Provides 3rd Quarter Conference Call Details 2
(Date:7/29/2015)... Rosa, CA (PRWEB) , ... July 29, 2015 , ... ... hernias have advanced as a result. Information provided by the National Center for ... – and three million new cases are reported annually. While the only effective ...
(Date:7/29/2015)... ... 2015 , ... ITW Dynatec, along with Zip-Pak and Valeron, ... responsible for driving growth and innovation across ITW Dynatec’s worldwide customer base and ... effective leader within the ITW community speaks for itself. We are delighted to ...
(Date:7/28/2015)... ... July 29, 2015 , ... ... lawyers and other A-Listers, has evolved into a world class millionaires club, according ... strives to match successful and attractive people seeking real, meaningful and mutually beneficial ...
(Date:7/28/2015)... , ... July 29, 2015 , ... ... Susan Bentley as a 2015-2016 inductee into its VIP Woman of the ... NAPW is the nation's leading networking organization exclusively for professional women, boasting more ...
(Date:7/28/2015)... ... July 28, 2015 , ... Every July, since 2007, about 25 pediatric ... experience through movies and television. They go to summer camp. , PH is incurable ... the heart as it pushes hard to get blood through arteries in the lungs ...
Breaking Medicine News(10 mins):Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 2Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3Health News:Meet a Millionaire Announces It’s Not a Sugar Daddy Site, It’s a True Millionaires Club 2Health News:National Association of Professional Women Inducts Susan Bentley, Owner of Women's Wellness Options, Into its VIP Woman of the Year Circle 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 3
... facing an increased threat of bird flu as new cases of ... Western Pacific has said though// Asian countries are planning and working ... should have been done and should be done to prevent bird ... to bird flu infection in East Asia since the re-emergence of ...
... NHS fund has lead to cancellation of subsidized flexible working ... introduced four years back by the Government is being rolled ... Private hospitals have also showed interest to acquisition of NHS ... due to financial crisis. ,Last year the government ...
... have an increased cancer risk, according to Belgian researchers.,The study, ... was reported online in The Lancet Oncology. // ... Due to its slow half-life, it accumulates in the body ... excreted in a person's urine can be used as a ...
... researchers are exploring the possibility for using Kaiso protein ... developing this new approach to treat intestinal cancer at ... Prokhorchuk's guidance jointly with American colleagues sponsored by the ... and Innovation. ,Any cancerous disease changes the ...
... 7 million lives every year, according to the WHO. Scientists ... behind this complex disease. Now they have a new research ... in the January 15 advance online publication of Nature Genetics, ... Medical College of Wisconsin (MCW) conducted systematic breeding and study ...
... watches more comedy films, which makes a person laugh, according ... to watch 15 to 30 minute segments of sad and ... ,Participants were asked to abstain from drinking alcohol, ... before the experiment, as all these can affect blood flow. ...
Cached Medicine News:Health News:Methyl-DNA binding Proteins To Fight Cancer 2Health News:Designer Rats Reveal Possible Heart Disease Genes 2
... lead family features St. Jude ... The lead is available in ... and silicone (IsoFlex S lead) ... models, and multiple lead lengths, ...
... Veriteq's Refrigerator and Freezer Monitoring ... monitoring system for refrigerators and ... install. Using a building's existing ... Freezer monitoring solution automates the ...
Antiseptic - Antibacterial Sudsing Cleanser...
HIBICLENS' non-drying, low skin irritation potential promotes compliance with the frequent hand washing associated with today's clinical protocols....
Medicine Products: